Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cordis Endovascular Systems (US) files patent suit against Target:

This article was originally published in Clinica

Executive Summary

Cordis Endovascular Systems (US) has filed suit in the San Jose District Court against Target Therapeutics (US), alleging infringement of its patents on microcatheters, guidewires and guiding catheters used to diagnose and treat disorders of the brain, liver and other internal organs (US Patent Nos 4,596,563; 4,846,186; and 5,171,232). Target products alleged to infringe the patents, which were filed in March 1984, include lines of Tracker and FasTracker microcatheters, Dasher guidewires and FasGuide guiding catheters.

You may also be interested in...



Cybersecurity: Guidance Docs To Come, But Legacy Devices Still A Challenge

Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.

Majority Of Spanish OTC Firms Investing Heavily In Digital

A recent ANEFP survey shows that the majority of Spanish OTC firms consider their digital strategies to be "very advanced."

Recent And Upcoming FDA Advisory Committee Meetings

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.

Topics

UsernamePublicRestriction

Register

MT093564

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel